Philip R. Lee Institute for Health Policy Studies

Philip R. Lee Institute for Health Policy Studies
PRL-IHPS contributes to the solution of complex and challenging health policy problems through leadership in research, training, technical assistance, and public service.
Masters of Science in Health Policy and Law
Learn more about the new on-line Masters of Science in Health Policy and Law Degree Program at UCSF and UC Hastings College of Law.
Hal Luft Award Winner 2017
In recognition of UCSF faculty who are engaged in health services and/or health policy research in their mentoring roles which demonstrate the qualities exemplified by Dr. Harold Luft.


Featured Story-

California Faces Shortage of Primary-Care Physicians
by 2025

A recent report from the @UCSF Healthforce Center states that by 2025, California will have a shortage of about 4,700 primary-care physicians.

The state currently has a population close to 40 million people. By 2050, California could have 50 million residents, according to the Public Policy Institute of California.

While a third of Californians rely on the state-federal insurance program for coverage, a recent study found that 36% of California doctors refuse to see Medi-Cal patients because of relatively low reimbursement rates.

Read more

What's Next for the Affordable Care Act?

Separating fact from rhetoric as we compare the Affordable Care Act, or Obamacare, with the GOP replacement plan. Jane McMillan looks at the proposed plan with Professor of Medicine Dr. Andrew Bindman. Dr. Bindman has practiced, taught and done research affiliated with San Francisco General, and is currently part of the Philip R. Lee Institute for Health Policy Studies at UCSF. His expertise on Medicaid policies and access to care was drawn on in the drafting of some of the legislative language in the Affordable Care Act.  

Listen to Interview

How much would CVS’s 7-day limit on painkiller prescriptions
help solve the opioid crisis?

The opioid crisis has reached epidemic status. And today, the country’s largest pharmacy chain has pledged its support to help.

CVS Pharmacy has announced it will limit opioid prescriptions to seven days for certain conditions for new patients seeking drugs for pain relief. The pharmacy will also put a limit of pain pills they dispense based on their strength.

Guests: Anna Lembke, M.D., head of the Stanford Addiction Medicine Dual Diagnosis Clinic
Adams Dudley, M.D., professor of medicine and health policy and director of the Center for Healthcare Value at UC San Francisco

Listen to Interview